Delivery Order SPE2DB22D1106-SPE2DB25FFCT5
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,814.83 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on June 2, 2025, with an ultimate completion date of June 3, 2025, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,302.14 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), a medication used to treat attention deficit hyperactivity disorder. The contract is a firm fixed price delivery order with no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement. The award was issued on September 24, 2025, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a $1,896.96 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,154.08 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL), a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.51 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml Suspension (180 ml), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,488.90 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (60 mL), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,050.33 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (180 mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $1,182.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (150 ml), with an ultimate completion date of June 20, 2025. This non-set-aside award was issued on June 18, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $2,962.82, represents a non-competitive set-aside award and is scheduled for completion by September 23, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.90 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (180 mL), a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on August 6, 2025, is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...